-30.3%
STX vs MRNA
+293.7%
-324.0%
-57.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.3% | -4.8% | +7.1% | +2.2% |
| 7D | -6.5% | -20.9% | +14.4% | -7.0% |
| 30D | -21.9% | -13.3% | -8.7% | -22.1% |
| 3M | -42.9% | +212.6% | -255.4% | -37.5% |
| 6M | -30.3% | +309.0% | -339.3% | -32.0% |
| All | -30.3% | +293.7% | -324.0% | -32.0% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling